Decreasing inappropriate MRCP with contrast exams: impact of an EMR-Embedded clinical care pathway
- PMID: 40439723
- DOI: 10.1007/s00261-025-05022-7
Decreasing inappropriate MRCP with contrast exams: impact of an EMR-Embedded clinical care pathway
Abstract
Purpose: Decrease unnecessary abdominal MRI with intravenous contrast with MRCP exams for emergency department and inpatients.
Methods: Our institution's two MRCP orders were removed from the electronic medical record (one with intravenous (IV) contrast and the other without), with all providers directed to a new MRCP clinical care pathway containing clinical guidance and links to the appropriate orders based on indication and patient characteristics. Before and after deployment, a random set of MRCP with contrast orders were reviewed for clinical appropriateness of needing IV contrast. A manual tracking of "patient in room" time was performed to compare MRI resource use for MRCP exams with contrast vs. non-contrast. A commercial clinical decision support (CDS) tool was active throughout the study period. Statistical significance was assessed with Chi-square test.
Results: At baseline, 71% (142/200) of MRCP exams were completed with contrast and 29% (58/200) without contrast. After two plan-do-study-act (PDSA) cycles, percentage of MRCPs performed with contrast decreased to 56% (p = 0.003), a 22% relative decrease, and MRCPs performed without contrast increased to 44%, a 53% relative increase. At baseline, contrast use was deemed inappropriate in 54% (29/54) of MRCP studies. Reassessment after PDSA cycle 1 showed a decrease in inappropriate MRCP with contrast orders to 25% (9/36), a 53% relative decrease (p = 0.007). Mean "in room" time was 11.5 min longer for MRCP with contrast exams.
Conclusion: Despite CDS, MRCP with contrast orders were deemed inappropriate 54% of the time at baseline. Redesigning the MRCP ordering process via creation of a pathway with embedded clinical guidance significantly decreased the proportion of contrast-enhanced MRCP exams by 22% and improved relative clinical appropriateness of MRCP with contrast exams by 62%. Properly directing ordering providers to non-contrast MRCP orders can help reduce healthcare costs, reduce unnecessary gadolinium exposure, and improve MR scanner efficiency.
Keywords: Clinical pathway; Contrast; MRCP; Order entry; Quality improvement.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- McDonald RJ, Weinreb JC, Davenport MS. Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term. Radiology. 2022;302(2):270–3. Epub 20211116. doi: https://doi.org/10.1148/radiol.2021211349 . PubMed PMID: 34783590. - DOI - PubMed
-
- American College of Radiology ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. 2024.
-
- Ludwig DR, Itani M, Childs DD, Revzin MV, Das KK, Anderson MA, et al. Biliary Duct Dilatation: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2024;222(4):e2329671. Epub 20230726. doi: https://doi.org/10.2214/ajr.23.29671 . PubMed PMID: 37493325. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
